Timely Insights for Healthcare Experts
CMS Reshapes and Finalizes “Promoting Interoperability” Rule as Providers Transition to Stage 3 in 2019
Following the Centers for Medicare & Medicaid Services’ (CMS) April 2018 rule proposal comes the finalization of the “Promoting Interoperability” rule (PI, formerly known as the Meaningful Use program). CMS hopes that by reshaping the rule to be more concise and less...
read more
Annual World Breastfeeding Week and the Benefits of Breastfeeding
August kicks off with World Breastfeeding Week, now on its 27th year since it was first celebrated by the World Alliance for Breastfeeding Action (WABA) in 1992. Every August 1-7, WABA partners with a worldwide network of organizations to encourage...
read more
FDA Grants Approval for First Targeted Anticancer Treatment for Relapsed or Refractory Acute Myeloid Leukemia with IDH1 Mutation
On July 20, 2018, the U.S. Food and Drug Administration (FDA) approved the first acute myeloid leukemia treatment. It is the first approved targeted cancer therapy for patients with relapsed or refractory acute myeloid leukemia (R/R AML), specifically,...
read more
What you need to know about Herbal-Drug Interactions
Evidence that Adverse Drug Interactions Occur from Herbal-Drug Interactions and Non-Prescription Drug Interactions. “Natural” is widely perceived by the public to ensure safety. However, studies show drug interactions with active pharmaceutical agents, and...
read more